In 2023, Bronson Crouch earned $1.14M in total compensation at Instil Bio, including $684.65K salary and $423.83K bonus. Most recently acquired 450,000 shares in Mar 2021. Currently holds stock worth $327.60M. 7+ years at the helm of Instil Bio.
Compensation History
Annual executive compensation data for Bronson Crouch, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$1.14M
Salary
$684.65K
Bonus
$423.83K
Other
$31.70K
Salary
$684.65KBoard Justification
The compensation philosophy is designed to attract and retain top talent while aligning executive compensation with company performance and shareholder interests.
Bonus
$423.83KBoard Justification
Represents discretionary retention bonus payments, which are subject to repayment to the Company in full within 30 days of termination in the event the named executive officer resigns without good reason or is terminated for cause at any time on or prior to February 22, 2024.
Other Compensation
$31.70KBoard Justification
Includes $12,095 in employer contributions to a 401(k) plan and $17,072 in employer contributions to health insurance coverage.
Restricted Stock
Board Justification
No stock was reported as vested in 2023.
Performance Metrics
The performance metrics for the CEO's compensation in 2023 were based on the achievement of corporate goals.
Bronson Crouch
CEO of Instil Bio
Field of Expertise
Finance & Banking - Venture Capital
Sector of Economy
Healthcare
CEO of Instil Bio for
7 years 1 month (Nov 2018 - Present)
Previous Experience
Founding Partner of Curative Ventures Management LLC since January 2014
Holdings
Track Bronson Crouch's stock holdings and portfolio value over time.
Insider Trading
Bronson Crouch's recent stock transactions, purchases, and sales filed with the SEC.
$9.00M
TIL at $20.00/share
Mar 23, 2021
Purchase
Rivals
Compare Bronson Crouch with competitor CEOs and industry peers.